Ironwood Pharma (IRWD) Tops Q4 EPS by 5c, Revenues Beat; Offers FY19 Revenue Mid-Point Guidance Above Consensus

Go back to Ironwood Pharma (IRWD) Tops Q4 EPS by 5c, Revenues Beat; Offers FY19 Revenue Mid-Point Guidance Above Consensus
IRONWOOD PHARMA-A (NASDAQ: IRWD) Delayed: 3.83 +0.01 (0.26%)
Previous Close $3.82    52 Week High $16.89 
Open $3.77    52 Week Low $7.35 
Day High $3.92    P/E N/A 
Day Low $3.76    EPS $-2.35 
Volume 1,008,961